ask="3.58"
ask_size="900"
average_daily_volume="562308"
bid="3.23"
bid_size="500"
book_value="5.03"
change="+0.08"
change_from_200_day_moving_average="0.33"
change_from_50_day_moving_average="0.95"
change_from_52_week_high="-15.92"
change_From_52_week_low="1.73"
change_in_percent="+2.42%"
close="3.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.22"
ebitda="-104.38M"
eps_estimate_current_year="-9.44"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-5.02"
ex_dividend_date="N/A"
float_shares="9594000"
high="3.49"
high_52_weeks="19.30"
last_trade_date="1/24/2017"
last_trade_price="3.38"
last_trade_size="2900"
last_trade_time="4:00pm"
low="3.21"
low_52_weeks="1.65"
market_capitalization="49.30M"
moving_average_200_day="3.05"
moving_average_50_day="2.43"
name="Orexigen Therapeutics
Inc."
notes="N/A"
one_year_target_price="11.67"
open="3.29"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+10.78%"
percent_change_from_50_day_moving_average="+38.90%"
percent_change_from_52_week_high="-82.49%"
percent_change_from_52_week_low="+104.85%"
previous_close="3.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.66"
price_per_sales="1.94"
revenue="24.76M"
shares_outstanding="14586000"
short_ratio="7.56"
stock_exchange="NMS"
symbol="OREX"
volume="362367"
weeks_range_52="1.65 - 19.30"
